Recently, KornnacCaps, a leading enterprise in China's empty capsule industry, announced the successful shipment of a batch of its high-quality empty capsule products to Brazil. This achievement marks a significant breakthrough in the company's strategic expansion into the South American market and highlights the competitiveness and influence of Chinese pharmaceutical excipient companies in the global supply chain.
It is reported that this export to Brazil includes two main series of products, gelatin capsules and vegetable capsules, totaling 50 million capsules. These will be primarily used for pharmaceutical production by local Brazilian companies. To ensure the products met both international standards and the specific requirements of the Brazilian client, KornnacCaps implemented strict control over every stage, from raw material procurement and production processes to quality testing. All products are certified by international standards such as the U.S. FDA and the European CE, and were also specifically adapted to meet the regulatory requirements of Brazil's Health Surveillance Agency (ANVISA), ensuring optimal performance in key indicators like stability and dissolution rate.
"Brazil, as the largest pharmaceutical market in South America, has extremely stringent quality requirements for pharmaceutical excipients. This collaboration is a full recognition of KornnacCaps' product quality and technical strength," stated the head of KornnacCaps International Trade Department. To ensure efficient delivery, the company formed a dedicated service team that provided an one-stop solution, from initial client consultation and customized production plan design to international logistics coordination. Addressing challenges such as long shipping times and complex customs clearance procedures, the team communicated proactively with local Brazilian partners to ensure a smooth process, ultimately delivering the goods five days ahead of schedule.
As a national high-tech enterprise, KornnacCaps has always centered its strategy on "driving quality upgrades through technological innovation." In recent years, the company has continuously increased its R&D investment, launching high value-added products such as enteric-coated capsules and sustained-release capsules, and has established a sales network covering over 50 countries and regions. The company's leadership emphasized, "The expansion into the Brazilian market is a crucial step in KornnacCaps's globalization strategy. Moving forward, we will continue to deepen our presence in the South American market, providing global clients with superior pharmaceutical excipient solutions through localized services and technological innovation, and helping the Chinese pharmaceutical industry chain make its mark on the world stage."
This successful export to Brazil not only brings new growth opportunities for KornnacCaps but also accumulates valuable experience for Chinese pharmaceutical excipient companies looking to expand internationally. With the growing global demand for high-quality excipients, KornnacCaps is gradually becoming a trusted partner for pharmaceutical companies worldwide, backed by its robust product strength and a global vision.
